This page is for parents looking to bring a WanaBana lawsuit on behalf of their child and their family for lead poisoning from this product.
Parents are angry and frustrated and want answers. This page provides answers for victims wondering what to do and how to seek settlement compensation. Our lawyers also provide the most recent information on the recall and the developments in the litigation, including the bankruptcy which may kill this litigation.
There is a new lawsuit involving the promotion and use of a dental device known as the Anterior Growth Guidance Appliance (AGGA). The lawsuit contends that the AGGA, which was marketed as a non-surgical solution for correcting dental, facial, and airway abnormalities, lacks scientific backing and has not been proven safe or effective for adult patients.
The core of the allegations centers on the assertion by the defendants that AGGA could induce substantial alterations in the adult nasomaxillary complex, including advancing the maxilla forward significantly, through mechanical force and bone growth stimulation.
Plaintiffs challenge these claims as unfounded and in direct conflict with established medical understanding, asserting that the device may, in fact, cause harm by displacing upper teeth from their sockets and leading to severe dental and skeletal issues.
As a result of the opioid addiction crisis, thousands of babies in the U.S. became addicted to opioids in utero and were born with Neonatal Abstinence Syndrome and suffered opioid withdrawal at birth. Parents of these children are now filing lawsuits against the opioid manufacturers. If your child was diagnosed with Neonatal Abstinence Syndrome or opioid withdrawal at birth, contact our national mass tort lawyers today to see if you qualify.
Over the past two decades, the number of opioid prescriptions has nearly quadrupled, fueling the ongoing opioid epidemic that has swept through our nation and brought devastation to countless families and communities. Recent estimates reveal that a baby born addicted to opioids emerges in the U.S. approximately every 19 minutes, with many newborns experiencing drug withdrawal symptoms and potential developmental issues daily.
The blame for this crisis often falls on drug manufacturers and distributors who knowingly played down the risks of opioid painkillers leading to physical dependency. Several pharmaceutical companies have faced repercussions for their deceptive and unlawful marketing of drugs like OxyContin, which, like other opiates, can serve as a gateway to heroin use. The consequences of Neonatal Abstinence Syndrome (NAS) can be profound, potentially resulting in lifelong complications and substantial medical costs that can place significant financial strain on families. You and your baby should not have to endure such traumatic circumstances.
Aqueous film-forming foam (“AFFF”) is generally known as firefighting foam and it has been used for decades to combat fires fueled by accelerants. AFFF contains high levels of chemicals called PFAS and recent research has shown that occupational exposure to PFAS can cause certain types of cancer. Kidney cancer is one of the diseases that has been scientifically linked to occupational exposure to AFFF firefighting foam.
This page will look at AFFF firefighting foam lawsuits involving kidney cancer and their potential settlement value.
A growing number of lawsuits are being filed against social media companies like Facebook, Instagram, and Snapchat, alleging that teens suffered physical and mental injuries after becoming addicted to social media. This page will explain the eligibility criteria for bringing a social media addiction lawsuit and how our firm screens potential social media addiction cases.
Over the last few years, a wave of injury lawsuits have been filed against social media platforms like Instagram, Facebook, and others, alleging that teens became addicted to these platforms and suffered physical and mental damage as a result. The social media lawsuits are based on two primary allegations: (1) the social media companies knowingly designed their platforms to get teenagers addicted to using them, and (2) addiction to social media caused significant physical and mental harm to younger users.
A new medical study has found that the chemicals in hair relaxers or straighteners can cause uterine cancer and other hormone-related conditions in women. Africa’s Best no-lye relaxer is one the more popular brands of hair relaxer, and it is manufactured by House of Cheatham, Inc. Hair relaxer lawsuits are being brought in all 50 states against House of Cheatham and other companies who sell chemical relaxer products. The lawsuits allege that relaxers such as Africa’s Best caused the plaintiffs to develop uterine cancer or other injuries.
This post will discuss the new medical evidence linking relaxers to uterine cancer and the lawsuits against House of Cheatham regarding Africa’s Best line of relaxer products.
Product safety testing discovered dangerous levels of benzene in several major brands of spray-on deodorant (and body spray).
Benzene is a notorious human carcinogen that has been shown to cause leukemia. Unsafe levels of the carcinogen were found in some of the most popular deodorant brands including Old Spice, Secret, Suave, and Tag. The FDA has established a benzene limit of 2 ppm in cosmetics. Yet, independent lab tests revealed that some recalled deodorants and antiperspirants had benzene concentrations as high as 9 ppm.
The discovery of benzene in spray-on deodorants could have major ramifications similar to those seen after benzene was found in sunscreen earlier this year. We could see sweeping product recalls before the end of 2021, followed by hundreds of product liability lawsuits against the deodorant manufacturers.
Next week, the pivotal first bellwether test trial is set to begin in the massive class action MDL over the personal and environmental harm caused by PFAS “forever chemicals” in AFFF firefighting foam. The firefighting foam MDL now has over 4,000 plaintiffs with pending cases. Now, after years of consolidated discovery and buildup, the test case is finally ready to be presented to a jury in a federal courtroom in South Carolina.
The case selected for this initial bellwether trial is the City of Stuart v. 3M Co. et al. (2:18-cv-03487). The outcome of the trial in the City of Stuart case will have a massive impact on the future course of the litigation. It will be the first time a jury will decide the scientific evidentiary battle that has been waged between the plaintiffs and defendants such as DuPont and 3M.
If the jury resolves this debate in favor of the plaintiff and awards a significant verdict, it could prompt a multi-billion-dollar settlement involving dozens of major companies. It could also set the stage for future cases involving similar tort claims by local municipalities based on environmental contamination.
Chemical hair relaxers and hair perms are products routinely used by a majority of African American women in the U.S. Scientific research has recently established that the chemicals in hair relaxers can cause endometrial cancer, and other serious health conditions.
Lawsuits are now being filed by women who may have developed endometriosis from prolonged use of hair perms or hair relaxers. There is a class action lawsuit ongoing in New York that has consolidated all endometriosis hair relaxers lawsuits together.
RELATED POSTS:
How much will a hair relaxer lawsuit be worth? Victims have many questions about hair relaxer settlements. But the biggest question we get is what settlement payouts can victims expect.
The emergence of the hair relaxer class action lawsuit has prompted speculation on how this litigation will play out and what a hair relaxer global settlement payout might look like.
In this post, our lawyers will look at the potential settlement value of hair relaxer lawsuits involving uterine cancer, and other conditions linked to hair relaxers.
Lawsuit Information Center